Related Experiment Video
Updated: May 1, 2026
Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
The selective cytotoxic anti-cancer properties and proteomic analysis of Trigonella Foenum-Graecum
Abdulaziz Alsemari1, Fahad Alkhodairy, Ahmad Aldakan
1Department of Neurosciences, King Faisal Specialist Hospital and Research Centre, PO box 3354, Riyadh 11211, Saudi Arabia. alsemari@kfshrc.edu.sa.
Background:
There are a number of dietary components that may prove useful in the prevention and treatment of cancer. In some cultures, fenugreek seeds are used to treat cancer. The current study focuses on the anticancer properties and proteomic profiles of fenugreek seeds, and is prompted by the clinical profile of a case of primary CNS T cell lymphoma that responded to fenugreek treatment and resulted in tumor regression.
Method:
Various normal and cancer cell lines were exposed to fenugreek extract at differing concentrations (100 μg/ml, 200 μg/ml and 300 μg/ml) and at different time points (0, 24, 48, 72 and 96 hrs). Protein fingerprints of fenugreek grain/seed types, obtained from four different geographical regions, were analyzed by proteomic expression profiles.
Results:
We observed selective cytotoxic effects of fenugreek extract in vitro to a panel of cancer cell lines, including T-cell lymphoma. Additionally, the cluster analysis of proteomics data showed that the protein profile of the particular fenugreek used by the patient is significantly different from three other regional subtypes of fenugreek extract.
Conclusion:
The in vitro effect of fenugreek as a substance with significant cytotoxicity to cancer cells points to the potential usefulness of fenugreek in the prevention and treatment of cancer.
Insights
Fenugreek extract shows selective cancer cell killing in lab studies, including T-cell lymphoma. Its unique protein profile may explain its potential as a natural cancer treatment.
Area of Science:
- Biochemistry
- Oncology
- Nutraceuticals
Background:
- Fenugreek seeds are traditionally used for cancer treatment in some cultures.
- A case study showed fenugreek's efficacy in treating primary CNS T cell lymphoma, prompting further investigation.
- Dietary components are increasingly recognized for their role in cancer prevention and management.
Purpose of the Study:
- To investigate the anticancer properties of fenugreek seeds.
- To analyze the proteomic profiles of fenugreek seeds from different geographical regions.
- To explore the potential of fenugreek as a cancer therapeutic agent.
Main Methods:
- In vitro exposure of normal and cancer cell lines to varying concentrations of fenugreek extract.
- Analysis of fenugreek seed protein fingerprints using proteomic expression profiles from four geographical regions.
- Assessment of cytotoxic effects at different time points (0-96 hours).
Main Results:
- Fenugreek extract demonstrated selective cytotoxicity against a panel of cancer cell lines, including T-cell lymphoma.
- Proteomic analysis revealed significant differences in the protein profiles of fenugreek subtypes.
- The specific fenugreek used in the patient case had a distinct protein profile compared to other regional variants.
Conclusions:
- Fenugreek exhibits significant in vitro cytotoxicity against cancer cells.
- These findings support the potential of fenugreek as a complementary agent in cancer prevention and treatment.
- Further research into fenugreek's specific compounds and mechanisms is warranted.
More Related Videos
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
10:18Author Spotlight: Exploring Seaweed's Bioactive Compounds for Sustainable Innovations in Industries
Published on: November 21, 2023
